Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5TS-1

PharmaCompass

01

Brand Name : TS-1

Oteracil Potassium

arrow
Antibody Engineering
Not Confirmed

Brand Name : TS-1

arrow
Antibody Engineering
Not Confirmed

Oteracil Potassium

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 68

2019 Revenue in Millions : 89

Growth (%) : -23

blank

02

Brand Name : TS-1

Oteracil Potassium

arrow
Antibody Engineering
Not Confirmed

Brand Name : TS-1

arrow
Antibody Engineering
Not Confirmed

Oteracil Potassium

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 51

2020 Revenue in Millions : 66

Growth (%) : -17

blank

03

Brand Name : TS-1

Oteracil Potassium

arrow
Antibody Engineering
Not Confirmed

Brand Name : TS-1

arrow
Antibody Engineering
Not Confirmed

Oteracil Potassium

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 54

2021 Revenue in Millions : 51

Growth (%) : 6

blank

04

Brand Name : TS-1

Oteracil Potassium

arrow
Antibody Engineering
Not Confirmed

Brand Name : TS-1

arrow
Antibody Engineering
Not Confirmed

Oteracil Potassium

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 53

2022 Revenue in Millions : 54

Growth (%) : 11

blank

05

Brand Name : TS-1

Oteracil Potassium

arrow
Antibody Engineering
Not Confirmed

Brand Name : TS-1

arrow
Antibody Engineering
Not Confirmed

Oteracil Potassium

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 87

2018 Revenue in Millions : 98

Growth (%) : -10

blank